The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages
Open accessAbstract
During the recent years, more attentions have been focused on lipid base drug delivery system to overcome some limitations of conventional formulations. Among these delivery systems solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) are promising delivery systems due to the ease of manufacturing processes, scale up capability, biocompatibility, and also biodegradability of formulation constituents and many other advantages which could be related to specific route of administration or nature of the materials are to be loaded to these delivery systems. The aim of this article is to review the advantages and limitations of these delivery systems based on the route of administration and to emphasis the effectiveness of such formulations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Solid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759
Solid lipid nanoparticles for parenteral drug delivery
Wissing, S. A., Kayser, O., & Müller, R. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.002 · Cited by 1,495
Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products
Pardeike, J., Hommoss, A., & Müller, R. H. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.10.003 · Cited by 1,478
Solid lipid nanoparticles (SLN) for controlled drug delivery – Drug release and release mechanism
zur Mühlen, A., Schwarz, C., & Mehnert, W. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00150-1 · Cited by 945
Muller, R. H., & Keck, C. M. (2004) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2004.06.007 · Cited by 819
Solid lipid nanoparticles as a drug delivery system for peptides and proteins☆
ALMEIDA, A., & SOUTO, E. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.007 · Cited by 814
Nanostructured lipid carriers: Promising drug delivery systems for future clinics
Beloqui, A., Solinís, M. Á., Rodríguez-Gascón, A., Almeida, A. J., & Préat, V. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.09.004 · Cited by 769
Constantinides, P. P. (1995) · Pharmaceutical Research · doi:10.1023/a:1016268311867 · Cited by 742
Souto, E. B., Wissing, S. A., Barbosa, C. M., & Müller, R. H. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.02.032 · Cited by 692
Potential of solid lipid nanoparticles in brain targeting.
Kaur, I. P., Bhandari, R., Bhandari, S., & Kakkar, V. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.018 · Cited by 615
Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles☆
WONG, H., BENDAYAN, R., RAUTH, A., LI, Y., & WU, X. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.008 · Cited by 578
Schwarz, C., Mehnert, W., Lucks, J. S., & Müller, R. H. (1994) · Journal of Controlled Release · doi:10.1016/0168-3659(94)90047-7 · Cited by 574
Weber, S., Zimmer, A., & Pardeike, J. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.08.013 · Cited by 568
Jenning, V., Gysler, A., Schäfer-Korting, M., & Gohla, S. H. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(99)00075-2 · Cited by 528
Solid lipid nanoparticles for targeted brain drug delivery.
BLASI, P., GIOVAGNOLI, S., SCHOUBBEN, A., RICCI, M., & ROSSI, C. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.011 · Cited by 506
Nanoparticle-Mediated Pulmonary Drug Delivery: A Review
Paranjpe, M., & Müller-Goymann, C. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15045852 · Cited by 454
Lipid nanoparticles for parenteral delivery of actives
Joshi, M. D., & Müller, R. H. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.003 · Cited by 433
Taratula, O., Kuzmov, A., Shah, M., Garbuzenko, O. B., & Minko, T. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.04.018 · Cited by 416
Martins, S., Sarmento, B. F. C. C., Ferreira, D., & Souto, E. B. (2007) · PubMed Central · Cited by 399
Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability
Luo, Y., Chen, D., Ren, L., Zhao, X., & Qin, J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.05.010 · Cited by 395
Lipid Nanoparticles with a Solid Matrix (SLN®, NLC®, LDC®) for Oral Drug Delivery
Muchow, M., Maincent, P., & Müller, R. H. (2008) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040802130061 · Cited by 394
Zhuang, C.-Y., Li, N., Wang, M., Zhang, X.-N., Pan, W.-S., Peng, J.-J., Pan, Y.-S., & Tang, X. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.05.005 · Cited by 318
Oral bioavailability of cyclosporine: Solid lipid nanoparticles (SLN®) versus drug nanocrystals
Müller, R. H., Runge, S., Ravelli, V., Mehnert, W., Thünemann, A. F., & Souto, E. B. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.02.045 · Cited by 304
Silva, A. C., González-Mira, E., García, M. L., Egea, M. A., Fonseca, J., Silva, R., Santos, D., Souto, E. B., & Ferreira, D. (2011) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2011.03.035 · Cited by 300
Doktorovová, S., Kovačević, A. B., Garcia, M. L., & Souto, E. B. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.08.001 · Cited by 293
Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery
Severino, P., Andreani, T., Macedo, A. S., Fangueiro, J. F., Santana, M. H. A., Silva, A. M., & Souto, E. B. (2012) · Journal of Drug Delivery · doi:10.1155/2012/750891 · Cited by 276
Lipid nanoparticles as novel delivery systems for cosmetics and dermal pharmaceuticals
Puglia, C., & Bonina, F. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.666967 · Cited by 253
Patlolla, R. R., Chougule, M., Patel, A. R., Jackson, T., Tata, P. N. V., & Singh, M. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.02.006 · Cited by 250
Solid lipid nanoparticles for ocular drug delivery
Seyfoddin, A., Shaw, J., & Al-Kassas, R. (2010) · Drug Delivery · doi:10.3109/10717544.2010.483257 · Cited by 247
Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel
Liu, D., Liu, Z., Wang, L., Zhang, C., & Zhang, N. (2011) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2011.02.038 · Cited by 245
CHEN, D.-B., YANG, T.-Z., LU, W.-L., & ZHANG, Q. (2001) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.49.1444 · Cited by 243
Luo, Q., Zhao, J., Zhang, X., & Pan, W. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.10.013 · Cited by 234
Nanomedicines for ocular NSAIDs: safety on drug delivery
Araújo, J., Gonzalez, E., Egea, M. A., Garcia, M. L., & Souto, E. B. (2009) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.02.003 · Cited by 223
Solid lipid nanoparticles as vehicles of drugs to the brain: Current state of the art
Gastaldi, L., Battaglia, L., Peira, E., Chirio, D., Muntoni, E., Solazzi, I., Gallarate, M., & Dosio, F. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.05.004 · Cited by 222
Pardeike, J., Weber, S., Haber, T., Wagner, J., Zarfl, H. P., Plank, H., & Zimmer, A. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.07.040 · Cited by 216
Shidhaye, S., Vaidya, R., Sutar, S., Patwardhan, A., & Kadam, V. (2008) · Current Drug Delivery · doi:10.2174/156720108785915087 · Cited by 210
Nafee, N., Husari, A., Maurer, C. K., Lu, C., de Rossi, C., Steinbach, A., Hartmann, R. W., Lehr, C.-M., & Schneider, M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.055 · Cited by 208 · cited 1×
“Noha Nafee 2014 (110) Quorum sensing inhibitors”
Narang, J., Khan, S., Baboota, S., Ali, J., Khan, S., & Narang, R. (2015) · International Journal of Pharmaceutical Investigation · doi:10.4103/2230-973x.167661 · Cited by 202
Attama, A. A., Reichl, S., & Müller-Goymann, C. C. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.12.007 · Cited by 200
Overcoming poor oral bioavailability using nanoparticle formulations – opportunities and limitations
Desai, P. P., Date, A. A., & Patravale, V. B. (2012) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2011.12.001 · Cited by 199
A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers
Li, X., Nie, S.-F., Kong, J., Li, N., Ju, C.-Y., & Pan, W.-S. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.07.017 · Cited by 195
Balguri, S. P., Adelli, G. R., & Majumdar, S. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.10.015 · Cited by 195
Makwana, V., Jain, R., Patel, K., Nivsarkar, M., & Joshi, A. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.09.014 · Cited by 189
Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route
Patel, S., Chavhan, S., Soni, H., Babbar, A. K., Mathur, R., Mishra, A. K., & Sawant, K. (2011) · Journal of Drug Targeting · doi:10.3109/1061186x.2010.523787 · Cited by 186
Sánchez-López, E., Espina, M., Doktorovova, S., Souto, E. B., & García, M. L. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.10.013 · Cited by 185
Barrier or carrier? Pulmonary surfactant and drug delivery
Hidalgo, A., Cruz, A., & Pérez-Gil, J. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.02.014 · Cited by 183
Mendes, A. I., Silva, A. C., Catita, J. A. M., Cerqueira, F., Gabriel, C., & Lopes, C. M. (2013) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2013.05.041 · Cited by 181
Adapalene loaded solid lipid nanoparticles gel: An effective approach for acne treatment
Jain, A. K., Jain, A., Garg, N. K., Agarwal, A., Jain, A., Jain, S. A., Tyagi, R. K., Jain, R. K., Agrawal, H., & Agrawal, G. P. (2014) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2014.05.041 · Cited by 176
Gainza, G., Pastor, M., Aguirre, J. J., Villullas, S., Pedraz, J. L., Hernandez, R. M., & Igartua, M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.032 · Cited by 172
Sánchez-López, E., Espina, M., Doktorovova, S., Souto, E. B., & García, M. L. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.10.009 · Cited by 172
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier
Dal Magro, R., Ornaghi, F., Cambianica, I., Beretta, S., Re, F., Musicanti, C., Rigolio, R., Donzelli, E., Canta, A., Ballarini, E., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.039 · Cited by 165
Application of lipid nanoparticles to ocular drug delivery
Battaglia, L., Serpe, L., Foglietta, F., Muntoni, E., Gallarate, M., del Pozo‐Rodríguez, A., & Solinís, M. Á. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1201059 · Cited by 161
Souto, E. B., & Müller, R. H. (2006) · Journal of Microencapsulation · doi:10.1080/02652040500435295 · Cited by 159
Chetoni, P., Burgalassi, S., Monti, D., Tampucci, S., Tullio, V. C., Cuffini, A., Muntoni, E., Spagnolo, R., Zara, G. P., & Cavalli, R. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.10.006 · Cited by 158
Tran, T. H., Ramasamy, T., Truong, D. H., Choi, H., Yong, C. S., & Kim, J. O. (2014) · AAPS PharmSciTech · doi:10.1208/s12249-014-0175-y · Cited by 153
Fangueiro, J. F., Andreani, T., Egea, M. A., García, M. L., Souto, S. B., Silva, A. M., & Souto, E. B. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.11.025 · Cited by 152
Ravi, P. R., Aditya, N., Kathuria, H., Malekar, S., & Vats, R. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.12.015 · Cited by 148
Topical Amphotericin B solid lipid nanoparticles: Design and development
Butani, D., Yewale, C. R., & Misra, A. R. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.07.032 · Cited by 143
Feasibility of Lipid Nanoparticles for Ocular Delivery of Anti-Inflammatory Drugs
Souto, E. B., Doktorovová, S., González‐Mira, E., Egea, M. A., & García, M. L. (2010) · Current Eye Research · doi:10.3109/02713681003760168 · Cited by 142
Štecová, J., Mehnert, W., Blaschke, T., Kleuser, B., Sivaramakrishnan, R., Zouboulis, C. C., Seltmann, H., Körting, H. C., Kramer, K. D., & Schäfer‐Korting, M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9225-9 · Cited by 140
Chen, J., Wei, N., Lopez-Garcia, M., Ambrose, D., Lee, J., Annelin, C., & Peterson, T. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.04.008 · Cited by 138
Jia, L., Zhang, D., Li, Z., Duan, C., Wang, Y., Feng, F., Wang, F., Liu, Y., & Zhang, Q. (2010) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2010.06.008 · Cited by 136
Lauterbach, A., & Müller-Goymann, C. C. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.06.020 · Cited by 135
Lipid-based carriers for pulmonary products: Preclinical development and case studies in humans
Cipolla, D. C., Shekunov, B. Y., Blanchard, J., & Hickey, A. J. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.05.001 · Cited by 132
Rao, S., & Prestidge, C. A. (2016) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2016.1151872 · Cited by 128
Wu, M., Fan, Y., Lv, S., Xiao, B., Ye, M., & Zhu, X. (2015) · Drug Delivery · doi:10.3109/10717544.2015.1058434 · Cited by 126
Nanostructured Lipid Carriers (NLC) for Parenteral Delivery of an Anticancer Drug
Chinsriwongkul, A., Chareanputtakhun, P., Ngawhirunpat, T., Rojanarata, T., Sila-on, W., Ruktanonchai, U., & Opanasopit, P. (2011) · AAPS PharmSciTech · doi:10.1208/s12249-011-9733-8 · Cited by 126
Vitorino, C., Almeida, A. J., Sousa, J., Lamarche, I., Gobin, P., Marchand, S., Couet, W. R., Olivier, J., & Pais, A. A. C. C. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.12.004 · Cited by 123
Islan, G. A., Tornello, P. R. C., Abraham, G. A., Durán, N., & Castro, G. R. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.03.040 · Cited by 120
Bhise, K., Kashaw, S. K., Sau, S., & Iyer, A. K. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.04.078 · Cited by 115
Gainza, G., Celdran‐Bonafonte, D., Moreno, B., Aguirre, J. J., Gutiérrez, F. B., Villullas, S., Pedraz, J. L., Igartua, M., & Hernández, R. M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.10.033 · Cited by 114
Cyclosporine-A incorporated cationic solid lipid nanoparticles for ocular delivery
Başaran, E., Demirel, M., Sırmagül, B., & Yazan, Y. (2010) · Journal of Microencapsulation · doi:10.3109/02652040902846883 · Cited by 114
Gonçalves, L., Maestrelli, F., Mannelli, L. D. C., Ghelardini, C., Almeida, A. J., & Mura, P. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.02.012 · Cited by 112
Montelukast-loaded nanostructured lipid carriers: Part I Oral bioavailability improvement
Patil-Gadhe, A., & Pokharkar, V. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.05.019 · Cited by 107
Almeida, H., Amaral, M. H., Lobão, P., Silva, A. C., & Lobo, J. M. S. (2014) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3dp43 · Cited by 105
Leonardi, A., Bucolo, C., Romano, G. L., Platania, C. B. M., Drago, F., Puglisi, G., & Pignatello, R. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.04.061 · Cited by 101
Nnamani, P. O., Hansen, S., Windbergs, M., & Lehr, C. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.10.004 · Cited by 97
Gönüllü, Ü., Üner, M., Yener, G., Karaman, E. F., & Aydoğmuş, Z. (2015) · Acta Pharmaceutica · doi:10.1515/acph-2015-0009 · Cited by 96
In vitro evaluation of idebenone-loaded solid lipid nanoparticles for drug delivery to the brain
Montenegro, L., Campisi, A., Sarpietro, M., Carbone, C., Acquaviva, R., Raciti, G., & Puglisi, G. (2011) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2010.539231 · Cited by 92
Ranpise, N. S., Korabu, S. S., & Ghodake, V. N. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2013.12.012 · Cited by 92
The use of nanoparticles as a promising therapeutic approach in cancer immunotherapy
Hosseini, M., Haji-Fatahaliha, M., Jadidi‐Niaragh, F., Majidi, J., & Yousefi, M. (2015) · Artificial Cells Nanomedicine and Biotechnology · doi:10.3109/21691401.2014.998830 · Cited by 90
Cirri, M., Mennini, N., Maestrelli, F., Mura, P., Ghelardini, C., & Mannelli, L. D. C. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.02.022 · Cited by 90
Lung-targeting delivery of dexamethasone acetate loaded solid lipid nanoparticles
Xiang, Q., Wang, M.-T., Chen, F., Gong, T., Jian, Y.-L., Zhang, Z., & Huang, Y. (2007) · Archives of Pharmacal Research · doi:10.1007/bf02980228 · Cited by 88
Moreno-Sastre, M., Pastor, M., Esquisabel, A., Sans, E., Viñas, M., Fleischer, A., Palomino, E., Bachiller, D., & Pedraz, J. L. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.12.028 · Cited by 87
Kim, J., Park, J., & Kim, C. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.09.008 · Cited by 85
Zhao, Y. J., Chang, Y., Hu, X., Liu, C., Quan, L., & Liao, Y. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.11.046 · Cited by 85
Patil-Gadhe, A., Kyadarkunte, A., Patole, M., & Pokharkar, V. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.07.007 · Cited by 84
Nunes, S., Madureira, A. R., Campos, D. A., Sarmento, B. F. C. C., Gomes, A., Pintado, M., & Reis, F. (2015) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2015.1031337 · Cited by 84
Makled, S., Nafee, N. A., & Boraie, N. A. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.12.026 · Cited by 82
Mussi, S. V., Sawant, R. R., Perche, F., Oliveira, M. C., Azevedo, R. B., Ferreira, L. A. M., & Torchilin, V. P. (2014) · Pharmaceutical Research · doi:10.1007/s11095-013-1290-2 · Cited by 80
Lohan, S. B., Bauersachs, S., Ahlberg, S., Baisaeng, N., Keck, C. M., Müller, R. H., Witte, E., Wolk, K., Hackbarth, S., Röder, B., et al. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.12.008 · Cited by 76
Halobetasol propionate-loaded solid lipid nanoparticles (SLN) for skin targeting by topical delivery
Bikkad, M. L., Nathani, A. H., Mandlik, S. K., Shrotriya, S. N., & Ranpise, N. S. (2013) · Journal of Liposome Research · doi:10.3109/08982104.2013.843192 · Cited by 73
Balguri, S. P., Adelli, G. R., Janga, K. Y., Bhagav, P., & Majumdar, S. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.06.042 · Cited by 72
Pardeike, J., Weber, S., Zarfl, H. P., Pagitz, M., & Zimmer, A. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.07.018 · Cited by 68
Ahmadnia, S., Moazeni, M., Mohammadi‐Samani, S., & Oryan, A. (2013) · Experimental Parasitology · doi:10.1016/j.exppara.2013.07.017 · Cited by 65
Self-citationGarg, A., Bhalala, K., Tomar, D. S., & Wahajuddin, M. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.10.064 · Cited by 64
Beloqui, A., Solinís, M. Á., Delgado, A., Évora, C., Isla, A., & Rodríguez‐Gascón, A. (2013) · Journal of Microencapsulation · doi:10.3109/02652048.2013.788090 · Cited by 60
Wang, X., Chen, H., Luo, Z.-G., & Fu, X. (2015) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2015.11.006 · Cited by 59
Lipid nanoparticles for brain targeting III. Long-term stability and in vivo toxicity
Blasi, P., Schoubben, A., Traina, G., Manfroni, G., Barberini, L., Alberti, P. F., Cirotto, C., & Ricci, M. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.06.037 · Cited by 59
Lipid nanoparticles for brain targeting I. Formulation optimization
Blasi, P., Giovagnoli, S., Schoubben, A., Puglia, C., Bonina, F. P., Rossi, C. R., & Ricci, M. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.07.035 · Cited by 56
Ferreira, M., Silva, E., Barreiros, L., Segundo, M. A., Lima, S. A. C., & Reis, S. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.08.008 · Cited by 55
Voriconazole-Loaded Nanostructured Lipid Carriers for Ocular Drug Delivery
Andrade, L. M., Rocha, K. A. D., de Sá, F. A. P., Marreto, R. N., Lima, E. M., Gratieri, T., & Taveira, S. F. (2016) · Cornea · doi:10.1097/ico.0000000000000825 · Cited by 54
Chen, D., Yang, T.-Z., Lü, W.-L., & Zhang, Q. (2002) · PubMed · Cited by 52
Topically applied lipid- and surfactant-based nanoparticles in the treatment of skin disorders
Desmet, E., Gele, M. V., & Lambert, J. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1206073 · Cited by 48
Modification of oral absorption of oxyresveratrol using lipid based nanoparticles
Sangsen, Y., Wiwattanawongsa, K., Likhitwitayawuid, K., Sritularak, B., & Wiwattanapatapee, R. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.04.055 · Cited by 45
Zeb, A., Qureshi, O. S., Kim, H.-S., Kim, M.-S., Kang, J.-H., Park, J., & Kim, J. (2017) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12727 · Cited by 45
Patil-Gadhe, A., & Pokharkar, V. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.01.080 · Cited by 44
Lipid nanoparticles for brain targeting II. Technological characterization
Blasi, P., Schoubben, A., Romano, G. V., Giovagnoli, S., Michele, A. D., & Ricci, M. (2013) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2013.04.021 · Cited by 41
Hommoss, G., Pyo, S. M., & Müller, R. H. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.04.009 · Cited by 37
Puglia, C., Lauro, M. R., Offerta, A., Crascì, L., Micicchè, L., Panico, A. M., Bonina, F. P., & Puglisi, G. (2016) · Planta Medica · doi:10.1055/s-0042-105293 · Cited by 36
Trends on polymer- and lipid-based nanostructures for parenteral drug delivery to tumors
Ajorlou, E., & Khosroushahi, A. Y. (2016) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-016-3168-6 · Cited by 35
Liu, D., Li, J., Cheng, B., Wu, Q., & Pan, H. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00069 · Cited by 35
Paranjpe, M., Finke, J. H., Richter, C., Gothsch, T., Kwade, A., Büttgenbach, S., & Müller-Goymann, C. C. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.09.031 · Cited by 33
Development of DH-I-180-3 loaded lipid nanoparticle for photodynamic therapy
Park, J.-H., Ban, S.-J., Ahmed, T., Choi, H. S., Yoon, H., Yoon, J., & Choi, H. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.07.002 · Cited by 24
Marto, J. M., Sangalli, C., Capra, P., Perugini, P., Ascenso, A., Gonçalves, L., & Ribeiro, H. M. (2017) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2017.1339083 · Cited by 16
Shah, M. R., Imran, M. A., & Ullah, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-52729-3.00001-9 · Cited by 9
Cited by
Gordillo-Galeano, A., & Mora-Huertas, C. E. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.10.017 · Cited by 569
Solid Lipid Nanoparticles vs. Nanostructured Lipid Carriers: A Comparative Review
Viegas, C., Patrício, A. B., Prata, J. M., Nadhman, A., Chintamaneni, P. K., & Fonte, P. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061593 · Cited by 524
Nanoparticles and its biomedical applications in health and diseases: special focus on drug delivery
Zahin, N., Anwar, R., Tewari, D., Kabir, M. T., Sajid, A., Mathew, B., Uddin, M. S., Aleya, L., & Abdel-Daim, M. M. (2020) · Environmental Science and Pollution Research · doi:10.1007/s11356-019-05211-0 · Cited by 371
Ghasemiyeh, P., & Mohammadi-Samani, S. (2020) · Drug Design, Development and Therapy · doi:10.2147/dddt.s264648 · Cited by 346
Self-citationEncapsulation of probiotics and nutraceuticals: Applications in functional food industry
Reque, P. M., & Brandelli, A. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.05.022 · Cited by 336
Metadata
- Authors
- Mohammadi-Samani, S., & Ghasemiyeh, P.
- Venue
- Research in Pharmaceutical Sciences
- Published
- 2018
- Volume
- 13
- Issue
- 4
- Pages
- 288
- ISSN
- 1735-5362 (ISSN-L)
- OpenAlex
- W2810248278
- Cited by
- 970
- References
- 116
- FWCI
- 22.25
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.